Csenge Advisory Group’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,478
| Closed | -$316K | – | 613 |
|
|
2022
Q2 | $316K | Sell |
1,478
-715
| -33% | -$153K | 0.03% | 437 |
|
|
2022
Q1 | $623K | Buy |
2,193
+530
| +32% | +$151K | 0.05% | 325 |
|
|
2021
Q4 | $620K | Sell |
1,663
-49
| -3% | -$18.3K | 0.06% | 292 |
|
|
2021
Q3 | $713K | Buy |
1,712
+49
| +3% | +$20.4K | 0.06% | 292 |
|
|
2021
Q2 | $620K | Buy |
1,663
+310
| +23% | +$116K | 0.06% | 293 |
|
|
2021
Q1 | $415K | Sell |
1,353
-25
| -2% | -$7.67K | 0.04% | 323 |
|
|
2020
Q4 | $344K | Sell |
1,378
-196
| -12% | -$48.9K | 0.04% | 294 |
|
|
2020
Q3 | $367K | Buy |
1,574
+5
| +0.3% | +$1.17K | 0.05% | 261 |
|
|
2020
Q2 | $274K | Sell |
1,569
-528
| -25% | -$92.2K | 0.04% | 290 |
|
|
2020
Q1 | $265K | Buy |
2,097
+743
| +55% | +$93.9K | 0.07% | 234 |
|
|
2019
Q4 | $207K | Buy |
+1,354
| New | +$207K | 0.05% | 274 |
|
|
2018
Q4 | – | Sell |
-714
| Closed | -$91K | – | 461 |
|
|
2018
Q3 | $91K | Buy |
+714
| New | +$91K | 0.04% | 246 |
|